AI assistant
HOLOGIC INC — Director's Dealing 2020
Jan 6, 2020
30407_dirs_2020-01-06_507e5951-f0e8-46d8-a364-3217d5aae06f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HOLOGIC INC (HOLX)
CIK: 0000859737
Period of Report: 2020-01-02
Reporting Person: Oberton Karleen Marie (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-02 | Common Stock | M | 10375 | $21.45 | Acquired | 39331 | Direct |
| 2020-01-02 | Common Stock | M | 5973 | $23.82 | Acquired | 45304 | Direct |
| 2020-01-02 | Common Stock | S | 10375 | $51.662 | Disposed | 34929 | Direct |
| 2020-01-02 | Common Stock | S | 5973 | $51.849 | Disposed | 28956 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-02 | Non-qualified Stock Option (Right to Buy) | $21.45 | M | 10375 | Disposed | 2020-11-18 | Common Stock (10375) | Direct |
| 2020-01-02 | Non-qualified Stock Option (Right to Buy) | $23.82 | M | 5973 | Disposed | 2021-05-26 | Common Stock (5973) | Direct |
Footnotes
F1: Transaction pursuant to an existing 10b5-1 trading plan.
F2: Includes 4,401 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
F3: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.55 to $51.785 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F4: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.535 to $52.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F5: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 18, 2013.
F6: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, May 26, 2014.